TTY Biopharm Company Limited
4105
Rank in Stocks
#10965
TTY Biopharm Company Limited, along with its associated entities, specializes... TTY Biopharm Company Limited, along with its associated entities, specializes in the creation and distribution of pharmaceutical and chemical products across Taiwan and global markets. Its operations are structured into several key divisions: Oncology, Intensive Care, Healthcare, Export & CDMO, and an "Other" Business Unit. For anti-cancer and supportive therapies, the company markets a range of oncology medications under prominent brand names such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. Addressing infectious diseases and influenza, TTY Biopharm supplies anti-infection drugs including Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. Furthermore, the firm offers various healthcare-related pharmaceuticals designed for the digestive system, osteoporosis, and metabolic conditions, marketed under brands like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. Beyond pharmaceuticals, the company is also involved in distributing functional foods, conducting international trade (import/export), and engaging in investment ventures. Established in 1960, TTY Biopharm maintains its principal office in Taipei, Taiwan.
Share Price
$2.50
Last synced: 2026-11-10
Market Cap
$622.31M
Change (1 day)
0.98%
Change (1 year)
-1.79%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade TTY Biopharm Company Limited (4105)
Category
Healthcare
EPS for TTY Biopharm Company Limited (4105)
EPS as of September 2026 TTM: $0.21
According to TTY Biopharm Company Limited's latest financial reports, its current EPS (TTM) is $0.21. At the end of 2025 the company had an EPS of $0.20, an increase over its 2024 EPS of $0.18.
EPS history for TTY Biopharm Company Limited from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.21 | 2.80% |
| 2025 | $0.20 | 12.50% |
| 2024 | $0.18 | 20.00% |
| 2023 | $0.15 | 3.14% |
| 2022 | $0.14 | 18.69% |
| 2021 | $0.12 | -8.69% |
| 2020 | $0.13 | 9.42% |
| 2019 | $0.12 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 3,062.16% |
DE
|
|
| $6.08 | 2,856.03% |
DE
|
|
| $1.55 | 654.18% |
JP
|
|
| $3.66 | 1,680.16% |
CH
|
|
| $0.45 | 118.87% |
IL
|
Questions about TTY Biopharm Company Limited's earnings per share (EPS)
What is TTY Biopharm Company Limited's earnings per share (EPS)?
TTY Biopharm Company Limited's earnings per share (EPS) over the last twelve months is $0.21, as of Sep 2026.
What was TTY Biopharm Company Limited's earnings per share (EPS) in 2025?
In 2025, TTY Biopharm Company Limited's earnings per share (EPS) was $0.20, 11.11% more than in 2024 ($0.18).
How has TTY Biopharm Company Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, TTY Biopharm Company Limited's earnings per share (EPS) went from $0.13 to $0.20, an average growth of 9.00% a year.
How does TTY Biopharm Company Limited's earnings per share (EPS) compare with similar companies?
TTY Biopharm Company Limited's earnings per share (EPS) ($0.21) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.